Adiponectin Decreases C-Reactive Protein Synthesis and Secretion From Endothelial Cells
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (7), 1368-1374
- https://doi.org/10.1161/atvbaha.108.163303
Abstract
Background and Objective—Inflammation is pivotal in atherosclerosis. C-reactive protein (CRP), in addition to being a cardiovascular risk marker, may also be proatherogenic. We have previously shown that in addition to the liver, human aortic endothelial cells (HAECs) synthesize and secrete CRP. Whereas CRP levels are increased in obesity, metabolic syndrome, and diabetes, levels of adiponectin are reduced in these conditions. We tested the hypothesis that adiponectin reduces CRP synthesis and secretion in HAECs under normoglycemic (5.5 mmol/L glucose) and hyperglycemic conditions (15 mmol/L glucose).Methods and Results—Adiponectin dose-dependently reduced CRP mRNA and protein from HAECs. Adiponectin treatment of HAECs significantly decreased IκB phosphorylation and NFκB binding activity. There was no effect of adiponectin on STAT or C/EBP transcriptional activity. Adiponectin also activated AMP kinase resulting in decreased NFκB activity and decreased CRP mRNA and protein. These effects of adiponectin were mimicked by AICAR, an activator of AMPK, and reversed by inhibition of AMPK. Thus, adiponectin reduces CRP synthesis and secretion from HAECs under hyperglycemia via upregulation of AMP kinase and downregulation of NFκB. Similar findings were observed in rat primary hepatocytes.Conclusions—Thus, in obesity and diabetes, the hypoadiponectinemia could exacerbate the proinflammatory state by inducing CRP production.Keywords
This publication has 42 references indexed in Scilit:
- CRP and Adiponectin and Its Oligomers in the Metabolic SyndromeAmerican Journal of Clinical Pathology, 2008
- High glucose induces IL-1β expression in human monocytes: mechanistic insightsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- The interaction of C-Rel with C/EBPbeta enhances C/EBPbeta binding to the C-reactive protein gene promoterMolecular Immunology, 2007
- Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ AgonistsThe American Journal of Cardiology, 2007
- Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cellsBiochemical and Biophysical Research Communications, 2005
- Stimulated HSP90 binding to eNOS and activation of the PI3–Akt pathway contribute to globular adiponectin-induced NO production: Vasorelaxation in response to globular adiponectinBiochemical and Biophysical Research Communications, 2005
- Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque InstabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- C-Reactive Protein and Other Inflammatory Biomarkers as Predictors of Outcome Following Acute Coronary SyndromesSeminars in Vascular Medicine, 2003
- Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from AtherosclerosisPublished by Elsevier BV ,2003
- Inflammation in atherosclerosisNature, 2002